The American Academy of Dermatology and National Psoriasis Foundation released new guidelines on the use of phototherapy for the treatment of psoriasis. Joel Gelfand, MD, MSCE, discussed the updated guidelines with The Dermatologist.
Access restrictions to therapies among patients with rheumatoid arthritis and psoriatic arthritis can significantly impact treatment effectiveness and adherence. Natalie Boytsov, PhD, discussed the implications of these restrictions with The Dermatologist.
Steve Bieler, National Psoriasis Foundation Staff Writer
The National Psoriasis Foundation is collaborating in a real-world trial evaluating the safety and effectiveness of home vs office phototherapy with the goals of providing important data for this therapeutic option and supporting patient-centered research. Dermatology practices can volunteer to act as clinical sites.